血清和心力衰竭的结果与减少的喷射分数:GALACTIC-HF试验
Misato Chimura1,2, Kieran F Docherty1, Pardeep S Jhund1
1British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
European heart journal
|August 31, 2025
概括
在心力衰竭患者中,高血 (高血清) 与排泄率减少 (HFrEF) 与不良事件的增加有关. 这项研究发现高磁血,而不是低磁血,增加了风险,表明可能需要针对性的干预措施.
科学领域:
- 心脏病学
- 电生理学
- 内部医学
背景情况:
- 血清含量及其对当代心力衰竭减少排气率 (HFrEF) 群体的预后影响仍未得到充分研究.
- 不正常的度可能会影响心血管结果,但大型HFrEF队列的数据有限.
研究的目的:
- 研究HFrEF患者血清度的频率和预后意义.
- 在 GALACTIC- HF 试验中评估基线含量与心血管不良结果之间的关联.
主要方法:
- 在随机双盲GALACTIC- HF试验中加入的6147名HFrEF门诊患者的血清数据的分析.
- 患者被分为三组:低血 (< 0. 75 mmol/ L),正常 (0. 75- 0. 95 mmol/ L) 和高血 (> 0. 95 mmol/ L).
- 主要综合结局是第一个恶化的心力衰竭事件或心血管死亡.
主要成果:
- 10. 7% 的患者表现出高磁血,而 17. 6% 的患者表现出低磁血.
- 主要综合结局的发病率在高磁血症患者 (34. 9/100人年) 和低磁血症患者 (21. 5) 或正常患者 (20. 9) 中是最高的.
- 过高血与因心力衰竭恶化的死亡风险增加有关,但水平异常与突然死亡或心室动脉节律失常的风险增加无关.
结论:
- 在HFrEF患者中,高血常见,这意味着心血管不良结果的风险更高,特别是心力衰竭的恶化.
- 低磁血症与主要综合结局或全因死亡的风险增加无关.
- 目前的研究结果不支持在HFrEF患者中常规纠正低磁血.
相关概念视频
01:30Heart Failure V: Medical Management
23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
01:22Heart Failure VI: Adjunct Therapies
27
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
27
01:26Heart Failure III: Clinical Manifestations
42
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
42
01:26Heart Failure Drugs: Inotropic Agents
717
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
717
01:29Heart Failure II: Pathophysiology
37
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
37
01:28Mitral Regurgitation IV: Nursing Management
80
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
80